Thomas L. Harrison, a director of Agenus Inc. (NASDAQ:AGEN), filed a Form 4 on August 7, 2026, disclosing the award of 50,000 stock options on August 5, 2026.

Key Highlights

  • Reporting person: Thomas L. Harrison, listed as a Director of Agenus Inc.
  • Transaction date: August 5, 2026, with 50,000 stock options acquired (transaction code A).
  • Exercise price: $7.78 per share, with an expiration date of August 5, 2036.
  • Price paid: $0.00 for the derivative security at award.
  • Vesting schedule: Options vest over three years, with one-third on the first anniversary of the grant date and the remaining two-thirds in two equal annual installments thereafter.
  • Beneficial ownership following transaction: 50,000 derivative securities, held directly.
  • Plan: Award made under the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan.

Agenus Director Thomas Harrison Awarded Stock Options Under 2019 Equity Plan

According to the Form 4 filing, Thomas L. Harrison, a director of Agenus Inc., received a stock option grant on August 5, 2026, covering 50,000 shares of Agenus common stock. The filing was signed by Melissa Orilall as Attorney-in-Fact for Thomas Harrison and submitted on August 7, 2026. The issuer is identified as Agenus Inc., trading on NASDAQ:AGEN.

The filing discloses that the stock options carry an exercise price of $7.78 per share and are set to expire on August 5, 2036. The price of the derivative security at the time of award was reported as $0.00. Following the transaction, Harrison beneficially owns 50,000 derivative securities, held directly. No non-derivative securities were reported in Table I of the filing.

As noted in the filing's explanation of responses, the options were "awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan," and "vest over three (3) years, with one-third (1/3) vesting on the first anniversary of the Grant Date and the remaining two-thirds (2/3) vesting in two equal annual installments thereafter." The filing was made by one reporting person and does not indicate any amendment to a prior filing.

What Was Disclosed

The filing reports the award of 50,000 stock options to Agenus director Thomas L. Harrison on August 5, 2026, at an exercise price of $7.78 per share, expiring August 5, 2036, under the company's 2019 Amended and Restated Equity Incentive Plan.